{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:21:22Z","timestamp":1783606882684,"version":"3.55.0"},"reference-count":23,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:p>Birt\u2013Hogg\u2013Dub\u00e9 syndrome (BHDS) is characterized by fibrofolliculomas, trichodiscomas, renal tumors, lung cysts, and spontaneous pneumothoraces. Other than renal cell carcinoma, no cancers have been confirmed as part of the BHDS tumor spectrum. Here, we set out to uncover if adrenocortical carcinoma (ACC) is associated with BHDS. A retrospective review at a single tertiary care center between 2010 and 2024 was performed using search terms describing the clinical manifestations of BHDS, adrenal tumors, and iterations thereof. The initial review identified 1,010 patients with ACC. Of these patients, 466 were evaluated by a genetic counselor, and 346 underwent genetic testing\u2014seven of which were found to have either characteristic clinical features of BHDS or a confirmed diagnosis. The literature review over the same time period demonstrated five additional cases of malignant adrenal tumors in patients with BHDS. We observed BHDS, confirmed by a pathogenic FLCN variant in 0.7% of all ACC patients, or 1.5% of patients evaluated by a genetic counselor and 2.0% of all patients who underwent genetic testing. Testing for FLCN pathogenic variants should be considered during routine genetic evaluation of patients with ACC, and special attention should be paid to adrenal tumors in BHDS patients during surveillance for renal neoplasms as more than 50% of patients in this series developed metastatic disease.<\/jats:p>","DOI":"10.1530\/erc-25-0285","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:45:39Z","timestamp":1773679539000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Adrenocortical carcinoma as a manifestation of Birt\u2013Hogg\u2013Dub\u00e9 syndrome"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8540-8248","authenticated-orcid":true,"given":"Katherine I","family":"Wolf","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenae","family":"Osborne","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M","family":"Lerario","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh N","family":"Vo","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Hamidi","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhammed Amir","family":"Habra","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hammer","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Else","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"2026070909442646400_bib1","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","article-title":"Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons","volume":"113","author":"Birt","year":"1977","journal-title":"Arch Dermatol"},{"key":"2026070909442646400_bib2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","article-title":"Birt-Hogg-Dube syndrome: diagnosis and management","volume":"10","author":"Menko","year":"2009","journal-title":"Lancet Oncol"},{"key":"2026070909442646400_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrurol.2015.206","article-title":"Molecular genetics and clinical features of Birt-Hogg-Dube syndrome","volume":"12","author":"Schmidt","year":"2015","journal-title":"Nat Rev Urol"},{"key":"2026070909442646400_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2011.12.008","article-title":"Association of adrenocortical carcinoma with familial cancer susceptibility syndromes","volume":"351","author":"Else","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2026070909442646400_bib5","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.lpm.2018.07.004","article-title":"Adrenocortical carcinoma (ACC): when and why should we consider germline testing?","volume":"47","author":"Petr","year":"2018","journal-title":"Presse Med"},{"key":"2026070909442646400_bib6","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026070909442646400_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jbi.2015.05.003","article-title":"Supporting information retrieval from electronic health records: a report of University of Michigan\u2019s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE)","volume":"55","author":"Hanauer","year":"2015","journal-title":"J Biomed Inform"},{"key":"2026070909442646400_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/cen.12292","article-title":"An oncocytic adrenal tumour in a patient with Birt-Hogg-Dube syndrome","volume":"80","author":"Raymond","year":"2014","journal-title":"Clin Endocrinol"},{"key":"2026070909442646400_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/10668969221117246","article-title":"Adrenal cortical carcinoma and additional rare pathologic findings in multi-organs in a Birt-Hogg-Dube syndrome patient: with an emphasis on the molecular characteristics of adrenal cortical carcinoma","volume":"31","author":"Kim","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"2026070909442646400_bib10","article-title":"Severe cholestatic jaundice (Stauffer syndrome) as a rare paraneoplastic manifestation in adrenocortical carcinoma","volume":"6","author":"Murvelashvili","year":"2022","journal-title":"J Endocr Soc"},{"key":"2026070909442646400_bib11","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.gim.2022.05.006","article-title":"Frequency of truncating FLCN variants and Birt-Hogg-Dube-associated phenotypes in a health care system population","volume":"24","author":"Savatt","year":"2022","journal-title":"Genet Med"},{"key":"2026070909442646400_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12022-023-09748-2","article-title":"FLCN-driven functional adrenal cortical carcinoma with high mitotic tumor grade: extending the endocrine manifestations of Birt-Hogg-Dube syndrome","volume":"34","author":"Hofstedter","year":"2023","journal-title":"Endocr Pathol"},{"key":"2026070909442646400_bib13","first-page":"58","volume":"26","author":"Juszczak","year":"2011","journal-title":"Endocrine Abstracts"},{"key":"2026070909442646400_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3315\/jdcr.2017.1242","article-title":"Birt-Hogg-Dube syndrome \u2013 report of two cases with two new mutations","volume":"11","author":"Rato","year":"2017","journal-title":"J Dermatol Case Rep"},{"key":"2026070909442646400_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-224283","article-title":"Oncocytoma of the adrenal gland in Birt-Hogg-Dube syndrome","volume":"2018","author":"Ramsingh","year":"2018","journal-title":"BMJ Case Rep"},{"key":"2026070909442646400_bib16","first-page":"49","article-title":"Birt-Hogg-Dube syndrome and coexistence with adrenocortical carcinoma","volume":"25","author":"Kalloniati","year":"2021","journal-title":"Hippokratia"},{"key":"2026070909442646400_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jmg.2009.070565","article-title":"Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and\/or multiple lung cysts are the presenting feature","volume":"47","author":"Kunogi","year":"2010","journal-title":"J Med Genet"},{"key":"2026070909442646400_bib18","volume-title":"Cancer Syndromes","author":"Reese","year":"2009"},{"key":"2026070909442646400_bib19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jnci\/dji154","article-title":"High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors","volume":"97","author":"Vocke","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2026070909442646400_bib20","first-page":"4583","article-title":"Inactivation of BHD in sporadic renal tumors","volume":"63","author":"Khoo","year":"2003","journal-title":"Cancer Res"},{"key":"2026070909442646400_bib21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.jid.5700592","article-title":"Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dube patients","volume":"127","author":"van Steensel","year":"2007","journal-title":"J Invest Dermatol"},{"key":"2026070909442646400_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccell.2016.07.013","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"30","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"2026070909442646400_bib23","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/3\/ERC-25-0285.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/3\/ERC-25-0285.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0285\/502906\/erc-25-0285.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0285\/502906\/erc-25-0285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:44:35Z","timestamp":1783604675000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/3\/e250285\/75523\/Adrenocortical-carcinoma-as-a-manifestation-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0285","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,1]]},"article-number":"e250285"}}